📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Predicting beneficial effects of atomoxetine and citalopram on response inhibition in Parkinson's disease with clinical and neuroimaging measures. (2016)

First Author: Ye Z

Attributed to: UKDP: Integrated DEmentiA research environment (IDEA) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/hbm.23087

PubMed Identifier: 26757216

Publication URI: http://europepmc.org/abstract/MED/26757216

Type: Journal Article/Review

Volume: 37

Parent Publication: Human brain mapping

Issue: 3

ISSN: 1065-9471